Previous close | 50.10 |
Open | 50.10 |
Bid | 51.30 |
Ask | 52.30 |
Strike | 92.50 |
Expiry date | 2025-01-17 |
Day's range | 50.10 - 50.10 |
Contract range | N/A |
Volume | |
Open interest | 41 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.